4//SEC Filing
Northpond Ventures, LP 4
Accession 0000899243-22-001631
CIK 0001827087other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 8:18 PM ET
Size
21.5 KB
Accession
0000899243-22-001631
Insider Transaction Report
Form 4
Northpond Ventures GP, LLC
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2022-01-11−1,027,978→ 0 total(indirect: By: Northpond Ventures II, LP)→ Common Stock (1,027,978 underlying) - Conversion
Common Stock
2022-01-11+2,831,520→ 2,831,520 total(indirect: By: Northpond Ventures, LP) - Conversion
Series A Preferred Stock
2022-01-11−2,831,520→ 0 total(indirect: By: Northpond Ventures, LP)→ Common Stock (2,831,520 underlying) - Conversion
Common Stock
2022-01-11+1,027,978→ 1,027,978 total(indirect: By: Northpond Ventures II, LP) - Purchase
Common Stock
2022-01-11$14.00/sh+355,000$4,970,000→ 1,382,978 total(indirect: By: Northpond Ventures II, LP)
Northpond Ventures, LP
10% Owner
Transactions
- Conversion
Common Stock
2022-01-11+1,027,978→ 1,027,978 total(indirect: By: Northpond Ventures II, LP) - Purchase
Common Stock
2022-01-11$14.00/sh+355,000$4,970,000→ 1,382,978 total(indirect: By: Northpond Ventures II, LP) - Conversion
Common Stock
2022-01-11+2,831,520→ 2,831,520 total(indirect: By: Northpond Ventures, LP) - Conversion
Series A Preferred Stock
2022-01-11−2,831,520→ 0 total(indirect: By: Northpond Ventures, LP)→ Common Stock (2,831,520 underlying) - Conversion
Series B Preferred Stock
2022-01-11−1,027,978→ 0 total(indirect: By: Northpond Ventures II, LP)→ Common Stock (1,027,978 underlying)
Northpond Ventures GP II, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-01-11$14.00/sh+355,000$4,970,000→ 1,382,978 total(indirect: By: Northpond Ventures II, LP) - Conversion
Series B Preferred Stock
2022-01-11−1,027,978→ 0 total(indirect: By: Northpond Ventures II, LP)→ Common Stock (1,027,978 underlying) - Conversion
Common Stock
2022-01-11+1,027,978→ 1,027,978 total(indirect: By: Northpond Ventures II, LP) - Conversion
Series A Preferred Stock
2022-01-11−2,831,520→ 0 total(indirect: By: Northpond Ventures, LP)→ Common Stock (2,831,520 underlying) - Conversion
Common Stock
2022-01-11+2,831,520→ 2,831,520 total(indirect: By: Northpond Ventures, LP)
Northpond Ventures II, LP
10% Owner
Transactions
- Conversion
Common Stock
2022-01-11+2,831,520→ 2,831,520 total(indirect: By: Northpond Ventures, LP) - Conversion
Series B Preferred Stock
2022-01-11−1,027,978→ 0 total(indirect: By: Northpond Ventures II, LP)→ Common Stock (1,027,978 underlying) - Conversion
Series A Preferred Stock
2022-01-11−2,831,520→ 0 total(indirect: By: Northpond Ventures, LP)→ Common Stock (2,831,520 underlying) - Purchase
Common Stock
2022-01-11$14.00/sh+355,000$4,970,000→ 1,382,978 total(indirect: By: Northpond Ventures II, LP) - Conversion
Common Stock
2022-01-11+1,027,978→ 1,027,978 total(indirect: By: Northpond Ventures II, LP)
Rubin Michael P.
10% Owner
Transactions
- Conversion
Common Stock
2022-01-11+2,831,520→ 2,831,520 total(indirect: By: Northpond Ventures, LP) - Purchase
Common Stock
2022-01-11$14.00/sh+355,000$4,970,000→ 1,382,978 total(indirect: By: Northpond Ventures II, LP) - Conversion
Common Stock
2022-01-11+1,027,978→ 1,027,978 total(indirect: By: Northpond Ventures II, LP) - Conversion
Series A Preferred Stock
2022-01-11−2,831,520→ 0 total(indirect: By: Northpond Ventures, LP)→ Common Stock (2,831,520 underlying) - Conversion
Series B Preferred Stock
2022-01-11−1,027,978→ 0 total(indirect: By: Northpond Ventures II, LP)→ Common Stock (1,027,978 underlying)
Footnotes (3)
- [F1]Immediately prior to the closing of the initial public offering of Vigil Neuroscience, Inc. (the "Issuer"), each share of Series A Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), of the Issuer and each share of Series B Preferred stock, par value $0.0001 per share of the Issuer (the "Series B Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). The right to convert the Series A Preferred Stock and Series B Preferred Stock into Common Stock had no expiration date.
- [F2]Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- [F3]Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
Documents
Issuer
Vigil Neuroscience, Inc.
CIK 0001827087
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001867472
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 8:18 PM ET
- Size
- 21.5 KB